Author:
Semrau Sabine,Waldfahrer Frank,Lell Michael,Linke Rainer,Klautke Gunther,Kuwert Torsten,Uder Michael,Iro Heinrich,Fietkau Rainer
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Radiology, Nuclear Medicine and imaging
Reference24 articles.
1. Abitbol A, Abdel-Wahab M, Lewin A, et al. A phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol. Int J Radiat Oncol Biol Phys 2002;53:942–7.
2. Adelstein DJ, Moon J, Hanna E, et al. Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216). Head Neck 2010;32:221–8.
3. Berger B, Belka C, Weinmann M, et al. Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol. Strahlenther Onkol 2010;186:255–61.
4. Calais G, Pointreau I, Alfons M, et al. Randomized phase III trial comparing induction chemotherapy using cisplatin, fluorouracil, with or without docetaxel for organpreservation in hypopharynx and larynx cacer. Preliminary results of the GORTEC 2000–01. ASCO Annual Meeting Proc 2006;24:5506.
5. Dirix P, Abbeel S, Vanstraelen B, et al. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys. 2009;75:385–92.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献